Chemical Compound

Atorvastatin EP Impurity F

CAS Registry Number 887196-24-9
Back to search Request a Quote
Atorvastatin EP Impurity F chemical structure
Primary Record

Atorvastatin EP Impurity F

In stock
5,171 g
Purity
99.4 %
CAS
887196-24-9

Compound Identifiers & Properties

CAS
887196-24-9
PubChem CID
57831782
SMILES
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)NCC[C@H](C[C@H](CC(=O)O)O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
Canonical SMILES
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)NCC[C@@H](O)C[C@@H](O)CC(=O)O

Names & Synonyms

  • Atorvastatin EP Impurity F
  • Atorvastatin IMpurity F
  • UNII-NM4ME645TL
  • NM4ME645TL
  • RefChem:69313
  • Atorvastatin Impurity 41
  • 887196-24-9
  • Atorvastatin Impurity 156
  • DTXSID20237275
  • SCHEMBL13734532
  • DTXCID20159766
  • Atorvastatin calcium trihydrate impurity F [EP]
  • ZINC67664912
  • ATORVASTATIN DIAMINO [USP IMPURITY]
  • IA71943
  • Atorvastatin EP Impurity F (Free Acid)
  • Atorvastatin calcium trihydrate impurity F
  • ATORVASTATIN DIAMINO (USP IMPURITY)
  • (3R,5R)-7-(((3R,5R)-7-(2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoyl)amino)-3,5-dihydroxyheptanoic acid
  • F19237
  • A900678
  • (3R,5R)-7-((3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoic acid
  • AtorvastatinN-(3,5-dihydroxy-7-heptanoic acid)amide
  • ATORVASTATIN CALCIUM IMPURITY F [EP IMPURITY]
  • Q27284945
  • ATORVASTATIN CALCIUM TRIHYDRATE IMPURITY F (EP IMPURITY)
  • ATORVASTATIN CALCIUM TRIHYDRATE IMPURITY F [EP IMPURITY]
  • Heptanoic acid, 7-(((3R,5R)-7-(2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrol-1-yl)-3,5-dihydroxy-1-oxoheptyl)amino)-3,5-dihydroxy-, (3R,5R)-
  • (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoic acid
  • (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5 -dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoic acid
  • (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoic acid
  • (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxyheptanoic acid
  • (3R,5R)-7-{(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanamido}-3,5-dihydroxyheptanoic acid
  • (3R,5R)-7-{(3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanamido}-3,5-dihydroxyheptanoic acid
  • Atorvastatin USP RC F; Atorvastatin Amide Impurity; Atorvastatin Di-Amide Acid; (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl] amino]-3,5-dihydroxy-heptanoic acid
  • Heptanoic acid, 7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-, (3R,5R)-